vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）とCSG SYSTEMS INTERNATIONAL INC（CSGS）の財務データ比較。上の社名をクリックして会社を切り替えられます
CSG SYSTEMS INTERNATIONAL INCの直近四半期売上が大きい（$323.1M vs $205.4M、COLLEGIUM PHARMACEUTICAL, INCの約1.6倍）。COLLEGIUM PHARMACEUTICAL, INCの純利益率が高く（8.3% vs 2.2%、差は6.1%）。COLLEGIUM PHARMACEUTICAL, INCの前年同期比売上増加率が高い（12.9% vs 2.0%）。COLLEGIUM PHARMACEUTICAL, INCの直近四半期フリーキャッシュフローが多い（$122.4M vs $55.8M）。過去8四半期でCOLLEGIUM PHARMACEUTICAL, INCの売上複合成長率が高い（19.1% vs 4.6%）
コレギウムファーマシューティカルは、乱用抑止機能を持つ革新的な疼痛管理治療薬の開発・販売を専門とする米国の製薬企業です。主に米国市場で慢性疼痛患者向け徐放性鎮痛剤を提供し、一般医療・専門医療現場の医療従事者向けに製品を展開しています。
中国南玻集団股フン有限公司は中国最大級の建築用ガラスメーカーで、浮きガラス、建築用ガラス、ディスプレイ用ガラス、自動車用ガラス、コーティングガラス、鏡、カラーフィルターガラス、太陽光発電用ガラス、省エネガラスなど多種多様なガラス製品の製造・販売を手がけています。
COLL vs CSGS — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $205.4M | $323.1M |
| 純利益 | $17.0M | $7.0M |
| 粗利率 | 62.5% | 50.0% |
| 営業利益率 | 29.6% | 9.0% |
| 純利益率 | 8.3% | 2.2% |
| 売上前年比 | 12.9% | 2.0% |
| 純利益前年比 | 35.3% | -79.7% |
| EPS（希薄化後） | $0.48 | $0.24 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $205.4M | $323.1M | ||
| Q3 25 | $209.4M | $303.6M | ||
| Q2 25 | $188.0M | $297.1M | ||
| Q1 25 | $177.8M | $299.5M | ||
| Q4 24 | $181.9M | $316.7M | ||
| Q3 24 | $159.3M | $295.1M | ||
| Q2 24 | $145.3M | $290.3M | ||
| Q1 24 | $144.9M | $295.1M |
| Q4 25 | $17.0M | $7.0M | ||
| Q3 25 | $31.5M | $20.5M | ||
| Q2 25 | $12.0M | $12.3M | ||
| Q1 25 | $2.4M | $16.1M | ||
| Q4 24 | $12.5M | $34.5M | ||
| Q3 24 | $9.3M | $19.1M | ||
| Q2 24 | $19.6M | $13.8M | ||
| Q1 24 | $27.7M | $19.5M |
| Q4 25 | 62.5% | 50.0% | ||
| Q3 25 | 61.7% | 48.1% | ||
| Q2 25 | 57.7% | 49.5% | ||
| Q1 25 | 54.8% | 48.4% | ||
| Q4 24 | 54.0% | 51.3% | ||
| Q3 24 | 60.8% | 49.4% | ||
| Q2 24 | 62.5% | 47.3% | ||
| Q1 24 | 63.1% | 46.5% |
| Q4 25 | 29.6% | 9.0% | ||
| Q3 25 | 29.7% | 10.0% | ||
| Q2 25 | 18.7% | 10.0% | ||
| Q1 25 | 12.2% | 9.8% | ||
| Q4 24 | 20.9% | 13.4% | ||
| Q3 24 | 21.9% | 10.8% | ||
| Q2 24 | 32.7% | 8.8% | ||
| Q1 24 | 34.1% | 10.8% |
| Q4 25 | 8.3% | 2.2% | ||
| Q3 25 | 15.0% | 6.7% | ||
| Q2 25 | 6.4% | 4.1% | ||
| Q1 25 | 1.4% | 5.4% | ||
| Q4 24 | 6.9% | 10.9% | ||
| Q3 24 | 5.9% | 6.5% | ||
| Q2 24 | 13.5% | 4.8% | ||
| Q1 24 | 19.1% | 6.6% |
| Q4 25 | $0.48 | $0.24 | ||
| Q3 25 | $0.84 | $0.73 | ||
| Q2 25 | $0.34 | $0.44 | ||
| Q1 25 | $0.07 | $0.57 | ||
| Q4 24 | $0.36 | $1.20 | ||
| Q3 24 | $0.27 | $0.67 | ||
| Q2 24 | $0.52 | $0.48 | ||
| Q1 24 | $0.71 | $0.68 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $386.7M | $180.0M |
| 総負債低いほど良い | — | $539.5M |
| 株主資本純資産 | $301.7M | $283.7M |
| 総資産 | $1.7B | $1.5B |
| 負債/資本比率低いほどレバレッジが低い | — | 1.90× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $386.7M | $180.0M | ||
| Q3 25 | $285.9M | $158.4M | ||
| Q2 25 | $222.2M | $145.9M | ||
| Q1 25 | $197.8M | $136.0M | ||
| Q4 24 | $162.8M | $161.8M | ||
| Q3 24 | $120.0M | $118.4M | ||
| Q2 24 | $271.6M | $110.4M | ||
| Q1 24 | $318.0M | $120.8M |
| Q4 25 | — | $539.5M | ||
| Q3 25 | — | $538.6M | ||
| Q2 25 | — | $537.8M | ||
| Q1 25 | — | $537.6M | ||
| Q4 24 | — | $538.5M | ||
| Q3 24 | — | $539.5M | ||
| Q2 24 | — | $540.5M | ||
| Q1 24 | — | $541.5M |
| Q4 25 | $301.7M | $283.7M | ||
| Q3 25 | $274.8M | $289.5M | ||
| Q2 25 | $232.2M | $290.7M | ||
| Q1 25 | $234.4M | $283.1M | ||
| Q4 24 | $228.8M | $282.6M | ||
| Q3 24 | $234.3M | $288.4M | ||
| Q2 24 | $216.6M | $273.3M | ||
| Q1 24 | $222.2M | $269.3M |
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.1B | $1.4B | ||
| Q1 24 | $1.1B | $1.3B |
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.86× | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 1.91× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 2.01× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $123.0M | $59.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $122.4M | $55.8M |
| FCFマージンFCF / 売上 | 59.6% | 17.3% |
| 設備投資強度設備投資 / 売上 | 0.3% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 7.25× | 8.46× |
| 直近12ヶ月FCF直近4四半期 | $327.6M | $141.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $123.0M | $59.2M | ||
| Q3 25 | $78.4M | $47.9M | ||
| Q2 25 | $72.4M | $37.3M | ||
| Q1 25 | $55.4M | $11.5M | ||
| Q4 24 | $84.6M | $82.5M | ||
| Q3 24 | $-9.0M | $39.5M | ||
| Q2 24 | $67.4M | $43.1M | ||
| Q1 24 | $61.9M | $-29.4M |
| Q4 25 | $122.4M | $55.8M | ||
| Q3 25 | $78.3M | $43.9M | ||
| Q2 25 | $72.4M | $34.6M | ||
| Q1 25 | $54.6M | $7.1M | ||
| Q4 24 | $84.1M | $76.6M | ||
| Q3 24 | $-9.2M | $32.0M | ||
| Q2 24 | $67.1M | $38.8M | ||
| Q1 24 | $61.4M | $-34.1M |
| Q4 25 | 59.6% | 17.3% | ||
| Q3 25 | 37.4% | 14.5% | ||
| Q2 25 | 38.5% | 11.6% | ||
| Q1 25 | 30.7% | 2.4% | ||
| Q4 24 | 46.2% | 24.2% | ||
| Q3 24 | -5.8% | 10.8% | ||
| Q2 24 | 46.2% | 13.4% | ||
| Q1 24 | 42.3% | -11.6% |
| Q4 25 | 0.3% | 1.1% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.4% | 1.5% | ||
| Q4 24 | 0.3% | 1.9% | ||
| Q3 24 | 0.2% | 2.5% | ||
| Q2 24 | 0.2% | 1.5% | ||
| Q1 24 | 0.4% | 1.6% |
| Q4 25 | 7.25× | 8.46× | ||
| Q3 25 | 2.49× | 2.34× | ||
| Q2 25 | 6.05× | 3.04× | ||
| Q1 25 | 22.92× | 0.71× | ||
| Q4 24 | 6.75× | 2.39× | ||
| Q3 24 | -0.96× | 2.07× | ||
| Q2 24 | 3.44× | 3.12× | ||
| Q1 24 | 2.23× | -1.51× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
COLL
セグメントデータなし
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
